Adaptimmune Therapeutics (ADAP)
(Delayed Data from NSDQ)
$1.05 USD
+0.04 (3.96%)
Updated May 24, 2024 04:00 PM ET
After-Market: $1.05 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -0.13 |
EPS Last Quarter | -0.18 |
Last EPS Surprise | -12.50% |
ABR | 2.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.67 |
Next Year | -0.57 |
EPS (TTM) | -0.83 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.00M | 4.00M | 22.20M | 21.50M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 4.00M | 4.00M | 22.20M | 21.50M |
Low Estimate | 4.00M | 4.00M | 22.20M | 21.50M |
Year ago Sales | 5.13M | 7.32M | 60.28M | 22.20M |
Year over Year Growth Est. | -22.03% | -45.36% | -63.17% | -3.15% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.13 | -0.15 | -0.67 | -0.57 |
# of Estimates | 2 | 1 | 2 | 2 |
Most Recent Consensus | -0.17 | -0.15 | -0.65 | -0.33 |
High Estimate | -0.09 | -0.15 | -0.65 | -0.33 |
Low Estimate | -0.17 | -0.15 | -0.69 | -0.80 |
Year ago EPS | -0.21 | -0.20 | -0.63 | -0.67 |
Year over Year Growth Est. | 38.10% | 25.00% | -6.35% | 15.67% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 2 | 2 |
Down Last 60 Days | 1 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.13 | -0.15 | -0.67 | -0.57 |
7 Days Ago | -0.13 | -0.15 | -0.67 | -0.57 |
30 Days Ago | -0.16 | -0.14 | -0.49 | -0.48 |
60 Days Ago | -0.13 | -0.12 | -0.44 | -0.42 |
90 Days Ago | NA | NA | -0.50 | -0.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.13 | -0.15 | -0.67 | -0.57 |
Zacks Consensus Estimate | -0.13 | -0.15 | -0.67 | -0.57 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.18 | -0.24 | -0.20 | -0.21 | NA |
Estimate | -0.16 | -0.12 | -0.20 | -0.17 | NA |
Difference | -0.02 | -0.12 | 0.00 | -0.04 | -0.05 |
Surprise | -12.50% | -100.00% | 0.00% | -23.53% | -34.01% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more